Health
Antibodies deplete cancer cells in mice and human cell lines; reach previously inaccessible targets – EurekAlert
Three studies – one each in Science, Science Translational Medicine, and Science Immunology – reveal the promise of newly engineered bispecific antibodies, including…
Three studies – one each in Science, Science Translational Medicine, and Science Immunology – reveal the promise of newly engineered bispecific antibodies, including by demonstrating their power against previously inaccessible tumor cell targets for the first time, in two cases. These bispecific antibodies, which simultaneously bind to tumor antigens and T cells, cleared cancer cells without damaging healthy cells in mouse tumor models and/or cell culture experiments, across the three studies. The…
-
General13 hours agoBritish and US planes fly 12-hour mission to patrol Russian border
-
Noosa News23 hours agoBrisbane muralist explains why he ended his plan to eat one chicken a day for a year
-
Noosa News17 hours agoWarm weather could make way for rain with ‘damaging winds, large hail’
-
General16 hours agoYoung boy flown to Brisbane hospital after K’gari dingo attack